Rare Disease Therapeutics

light bulb think theory idea bright dull lights out
Biotech

Small pools, big ideas: Rare disease community reimagines trials

To get rare disease drugs through FDA scrutiny and into the hands of patients, researchers and biopharma companies are getting creative.
Angus Liu Apr 17, 2026 3:00am
FDA stop sign
Favicon Fierce Pharma

FDA snubs Ultragenyx gene therapy over manufacturing issues

Jul 14, 2025 10:16am